Neuraxis NRXS
NYSE NRXS
$7.25 +0.08 (+1.12%)
As of: Oct 2, 2026 · 10:32 AM EDT

Neuraxis (NRXS) EPS (Diluted) (2022 - 2025)

Updated

Neuraxis' EPS (Diluted) was -$0.21 in Q4 2025, compared with -$0.23 a year earlier.

Analysis

Neuraxis (NRXS) EPS (Diluted) (2022 - 2025) Analysis & Trends

For FY2025, EPS (Diluted) at Neuraxis came in at -$0.95.

  • In earlier years, EPS (Diluted) was -$1.22 in FY2024, -$4.50 in FY2023 and -$2.77 in FY2022.
  • The Q4 2025 figure marks the highest quarterly EPS (Diluted) since Q4 2022.
  • Per Business Quant data, NRXS's EPS (Diluted) in the three quarters before Q4 2025 was -$0.24 (Q3 2025), -$0.22 (Q2 2025) and -$0.33 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 4.68
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 0.53
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 1.23
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 2.29
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 1.14
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 3.31
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 0.61
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 0.42
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 1.37
10 Neuraxis 91.64 Mn 66.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.21
Sep 30, 2025 -0.24
Jun 30, 2025 -0.22
Mar 31, 2025 -0.33
Dec 31, 2024 -0.23
Sep 30, 2024 -0.25
Jun 30, 2024 -0.42
Mar 31, 2024 -0.32
Dec 31, 2023 -1.63
Sep 30, 2023 -1.35
Jun 30, 2023 -1.21
Mar 31, 2023 -1.08
Dec 31, 2022 -0.10
Sep 30, 2022 -1.14
Jun 30, 2022 -0.87
API Access

Neuraxis EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=NRXS&period=max&api_key=YOUR_API_KEY